Key result
COVID-19 pandemic linked to ~109% higher odds of same-day discharge after elective PCI.
Why the study?
Same day discharge after elective PCI is safe and cost-efficient, but the impact of the COVID-19 pandemic on rates of same day discharge and care episode costs remained uncertain.
Does the COVID-19 pandemic increase the adoption of same-day discharge and affect costs in patients undergoing elective PCI?
Observational (n=12,740)
Yes
Does the COVID-19 pandemic increase the adoption of same-day discharge and affect costs in patients undergoing elective PCI?
The COVID-19 pandemic significantly accelerated the adoption of same-day discharge following elective PCI, which was associated with reduced episode costs.
Pandemic-linked rise in same-day discharge supports broader adoption in eligible patients; extends evidence on adaptive procedural pathways.
Background Elective percutaneous coronary intervention (PCI) historically required hospitalization post procedure. Same day discharge (SDD) has emerged as a safe and cost efficient option, although the impact of the coronavirus disease of 2019 (COVID-19) pandemic on rates of SDD and associated care episode costs remains uncertain. Methods A national sample of consecutive patients undergoing elective PCI at 42 hospitals (Ascension, St.Louis, MO) between May 2019 to April 2021 were identified using internal registry data and administrative claims data. Rates of SDD before and after the COVID-19 pandemic (March 2020) were compared using multivariable logistic regression adjusted for patient and procedural characteristics. Additionally, an interrupted time series model was used to determine the effect of the pandemic and policy on SDD rates before and after pandemic declaration. Lastly, we estimated total costs per PCI episode in pre and post pandemic periods. Results In total, 12,740 interventions were performed within 42 Ascension facilities that met study eligibility criteria (5955 PCI prior to the pandemic and 6785 after). Demographic data were similar between both populations although higher rates of dyslipidemia, prior myocardial infarction, and heart failure history were noted in the post pandemic group. Pandemic declaration was associated with a higher likelihood of SDD (OR 2.09, CI 1.93-2.25, p < 0.001). From pre-pandemic to post-pandemic, mean SDD rose from 34% to 45% (p< 0.001) with an accelerated monthly SDD adoption rate after the pandemic (0.1% per month vs 1.0% per month, p=0.02). Total costs per episode were $679.52 (95% CI $476.12 – $882.92, p < 0.001) higher in the post-pandemic period, driven by increased material costs. SDD was associated with a $2137.05 (95% CI $1925.03 – $2349.07, p < 0.001) reduction in costs relative to non-SDD episodes throughout the study period. Conclusion Among a large national risk-adjusted sample of consecutive patients, the COVID-19 pandemic accelerated adoption of SDD. As a care strategy, SDD was associated with reduced episode costs during elective PCI in the post-pandemic period.
No takes yet. Share an insight, caveat, or question.
Thangam et al. (2023) conducted an observational in Stable coronary artery disease (n=12,740). COVID-19 pandemic declaration vs. Pre-pandemic period was evaluated on Same-day discharge (SDD) rate (OR 2.09, 95% CI 1.93-2.25, p=<0.001). The COVID-19 pandemic declaration was associated with a significant increase in the rate of same-day discharge following elective percutaneous coronary intervention from 34% to 45% (OR 2.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: